Stewart Washer has 20 years of CEO and board experience in medical technology, biotech and agrifood companies. He is currently the chairman of Orthocell Ltd., which cultures tendon cells to repair damaged tendons, chairman of Cynata Therapeutics Ltd., which is developing stem cell therapies, and chairman of Minomic International Ltd., which has an accurate noninvasive test for prostate cancer. He was also a founder of a NZ$120M New Zealand-based life science fund and venture partner with the Swiss-based Inventages Nestlé Fund. He is currently investment director with Bioscience Managers.